NPC Research on Anticancer Medication Adherence at NCCN 2022 Annual Meeting

During this year's virtual NCCN 2022 Annual Meeting, NPC presented a poster featuring research on anticancer medication adherence. 

NPC was honored to be a part of the National Comprehensive Cancer Network (NCCN) 2022 Annual Meeting Poster Presentations on Thursday, March 31.

Poster Title: "Medication Adherence and Subsequent Healthcare Resource Utilization Among Patients with Cancer Newly Initiating their Oral Anticancer Medication" 

Background: The anticancer treatment landscape has changed considerably over the past decade with the introduction of many new oral medications. Non-adherence to oral anticancer medications (OAM) may lead to poorer health outcomes and increased healthcare resource utilization (HRU).

Objectives: To determine the association between medication adherence and subsequent all-cause HRU among patients who initiated OAM.


  • Andrew Descoteaux, MS, Graduate Teaching Assistant, University of Rhode Island
  • Stephen Kogut, PhD, MBA, Professor, College of Pharmacy, University of Rhode Island
  • Patrick Campbell, PharmD, PhD, Senior Director Research, Pharmacy Quality Alliance
  • Megha Parikh, PhD, MS, Senior Research Scientist
  • Amanda Green, MPH, Research Associate, National Pharmaceutical Council
  • Kimberly Westrich, MA, Vice President of Health Services Research, National Pharmaceutical Council
  • Ami Vyas, PhD, MS, MBA, Assistant Professor, HEOR, College of Pharmacy, University of Rhode Island 
value assessment computer

Learn More

For agenda, speaker and registration information, visit the NCCN 2022 Annual Meeting website.

Visit the Website